FDA Webview
X
latest-news

CBER director Vinay Prasad overrules the Center’s career reviewers in deciding to issue Moderna a refusal-to-file letter for its BLA for an influenza vaccine.

latest-news

The CDER Office of Prescription Drug Promotion cautions Janssen Biotech about a direct-to-consumer TV ad for Tremfya that misleadingly overstates the drug’s benefits and omits important risk information.

LATEST NEWS

View All
motusgi
CBER Head Overruled Staff on Moderna Flu Vaccine Filing

CBER director Vinay Prasad overrules the Center’s career reviewers in deciding to issue Moderna a refusal-to-file letter for its BLA for an influenza vaccine.

motusgi
FDA Hits Tremfya TV Ad as ‘False or Misleading’

The CDER Office of Prescription Drug Promotion cautions Janssen Biotech about a direct-to-consumer TV ad for Tremfya that misleadingly overstates the drug’s benefits and omits important risk information.

motusgi
Issues with AI-Enhanced Surgical Devices Cited

A detailed Reuters report looks at instances of surgical adverse events that may be related to artificial technology-enhanced medical devices being used in the procedures.

motusgi
FDA ‘Not Serious’ About Mifepristone Review: GOP Senators

Politico says some GOP senators expressed frustration with FDA over a lack of apparent progress on its supposed safety review of the abortion drug mifepristone.

newsletter-first

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Animal Drugs

View All
medical-devices
Read More
Sangamo Begins Rolling BLA for Fabry Gene Therapy

Sangamo Therapeutics begins a rolling BLA submission seeking accelerated approval of its experimental Fabry disease gene therapy, following result...

medical-devices
Read More
Sydnexis Pediatric Myopia Drug Meets Endpoints

Sydnexis says its SYD-101 drug to treat pediatric progressive myopia met both the primary and key secondary endpoints in the Phase 3 STAR trial.

medical-devices
Read More
10/9 Vaccines Panel to Recommend Flu Strain Selection

FDA schedules a 10/9 Vaccines and Related Biological Products Advisory Committee meeting to make recommendations on the strain selection for influenza...

medical-devices
Read More
Capsida Pauses Gene Therapy Trial After Death

Capsida Biotherapeutics stops enrollment in its SYNRGY clinical trial that is evaluating gene therapy CAP-002 for treating STXBP1 developmental and ep...

Biologics

View All
medical-devices
Read More
CBER Head Overruled Staff on Moderna Flu Vaccine Filing

CBER director Vinay Prasad overrules the Center’s career reviewers in deciding to issue Moderna a refusal-to-file letter for its BLA for an influenza ...

medical-devices
Read More
FDA Tags Data Integrity, Inventory Lapses in AGC Biologics 483

FDA cites AGC Biologics for deficiencies in laboratory data controls and inventory management at its Bothell, WA, drug substance manufacturing site.

medical-devices
Read More
Inhaled Gene Therapy for Lung Cancer Gets ‘Expedited’ Status

FDA awards Krystal Biotech a Regenerative Medicine Advanced Therapy designation for KB707, an inhalable gene therapy being investigated for treating l...

medical-devices
Read More
Aseptic Processing/Documentation Failures at Lonza Cell Therapy Facility

FDA cites Lonza Portsmouth for significant manufacturing and quality control deficiencies at its cell therapy facility where Vertex Pharmaceuticals an...

FDA General

View All
medical-devices
Read More
Trust in FDA and CDC Remains Low After Vaccine Changes

A new poll finds public confidence in FDA and Centers for Disease Control and Prevention remains low following recent changes to the federally recomme...

medical-devices
Read More
FDA’s Expanding Role, Staff Cuts Challenge Oversight: GAO

A new GAO report finds FDA’s regulatory responsibilities expanded substantially between fiscal years 2008 and 2024, and now it faces workforce reducti...

medical-devices
Read More
Guide on Device Cybersecurity Released

FDA posts a final guidance entitled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.

medical-devices
Read More
FDA Official’s Personal Legal Actions Trigger Ethics Probe

HHS Office of Inspector General begins an ethics investigation into FDA deputy chief of staff Samuel Doran and whether he misled the federal governmen...

newsletter-second

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Federal Register

View All
motusgi
Read More
PDUFA Public Meeting for User Fee Reauthorization

Federal Register notice: FDA announces a 7/14 public meeting to discuss proposed recommendations for...

motusgi
Read More
Generic Drug Fee Program Reauthorization Meeting

Federal Register notice: FDA hosts a 7/11 public meeting on the reauthorization of the Generic Drug ...

motusgi
Read More
FDA Withdraws and Reissues 2 Guidances

FDA says it is withdrawing two recent final guidances on cell- and tissue-based products and reissui...

motusgi
Read More
CDER Continues Quality Management Program

Federal Register notice: FDA seeks drug manufacturing establishments to participate in the second ye...

Human Drugs

View All
motusgi
Read More
FDA Hits Tremfya TV Ad as ‘False or Misleading’

The CDER Office of Prescription Drug Promotion cautions Janssen Biotech about a direct-to-consumer T...

motusgi
Read More
FDA ‘Not Serious’ About Mifepristone Review: GOP Senators

Politico says some GOP senators expressed frustration with FDA over a lack of apparent progress on i...

motusgi
Read More
Keytruda Regimen for PD-L1–Positive Ovarian Cancers Approved

FDA approves Merck’s Keytruda (pembrolizumab), as well as the fixed-dose combination pembrolizumab a...

motusgi
Read More
Biofrontera sNDA Seeks Expanded Ameluz Use

FDA accepts for review a Biofrontera supplemental NDA seeking to expand the label of its photodynami...

Marketing

View All
motusgi
Read More
Neffy Broadcast Ad ‘False or Misleading’: OPDP

An FDA Untitled Letter cautions ARS Pharmaceutical about false or misleading claims for its Neffy na...

motusgi
Read More
Cobenfy Ad Letter Signals Tight Limits on DTC Claims: Attorneys

A December FDA violation letter targeting a schizophrenia drug advertisement from Bristol Myers Sq...

motusgi
Read More
FDA Flags AstraZeneca’s Farxiga TV Ad as Misleading

FDA cites a direct-to-consumer television advertisement for AstraZeneca’s Farxiga (dapagliflozin) ta...

motusgi
Read More
Oversight of Influencer Social Media Posts Hard: Researchers

University of Chicago researchers explain how difficult it will be to improve government oversight o...

Medical Devices

View All
motusgi
Read More
Issues with AI-Enhanced Surgical Devices Cited

A detailed Reuters report looks at instances of surgical adverse events that may be related to artif...

motusgi
Read More
FDA OKs Novocure’s Optune Pax for Advanced Pancreatic Cancer

FDA approves Novocure’s Optune Pax for use in combination with gemcitabine and nab-paclitaxel for ad...

motusgi
Read More
FDA Reports Progress in MDUFA 6 Negotiations

FDA and industry representatives report agreement on several issues in the 1/21 MDUFA 6 negotiating ...

motusgi
Read More
FDA Clears Median’s AI Lung Cancer Screener

FDA clears a Median Technologies 510(k) for eyonis LCS, the first artificial intelligence–based devi...